On the recordSeptember 30, 2020
Why is it, in a free market economy, in the United States of America, you can't negotiate on behalf of 45 million Medicare beneficiaries for better drug prices?
Source
congress.govEditor's note · Context
Sarbanes questions the inability to negotiate drug prices for Medicare beneficiaries.
Share
More from John Sarbanes
Apr 25, 2023
As the Inflation Reduction Act reforms continue to be implemented over the coming years, we must continue to build on this success.
Mar 1, 2023
Due to testing positive for COVID-19 and following recommended isolation protocols, I was unable to vote. Had I been present, I would have voted ``aye'' on rollcall No. 125, ``aye'' on rollcall No. 126, ``aye'' on rollcall No. 127, ``aye''…
Mar 28, 2023
A strong, well-trained workforce is critical to ensuring a high-quality healthcare delivery system.
Oct 17, 2023
The health of the Chesapeake Bay and its watershed can only continue to improve through robust Federal, state, and local partnerships.
Other voices in this conversation
